comparemela.com

Stevenp James News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction - Ikena Oncology (NASDAQ:IKNA)

Ikena receives approximately $43 million in net cash at closing New capital will further accelerate and expand development of Ikena's targeted oncology pipeline BOSTON and SOUTH SAN FRANCISCO, Calif., Aug. 07, 2023

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.